254 related articles for article (PubMed ID: 18756365)
1. Monocationic radiotracer kinetics and myocardial infarct size: a perfused rat heart study.
Okada DR; Liu Z; Beju D; Okada RD; Johnson G
Ann Nucl Med; 2008 Aug; 22(7):617-27. PubMed ID: 18756365
[TBL] [Abstract][Full Text] [Related]
2. Detection of myocardial viability in ischemic-reperfused rat hearts by Tc-99m sestamibi kinetics.
Liu Z; Johnson G; Beju D; Okada RD
J Nucl Cardiol; 2001; 8(6):677-86. PubMed ID: 11725264
[TBL] [Abstract][Full Text] [Related]
3. 99mTc-sestamibi kinetics predict myocardial viability in a perfused rat heart model.
Liu Z; Okada DR; Johnson G; Hocherman SD; Beju D; Okada RD
Eur J Nucl Med Mol Imaging; 2008 Mar; 35(3):570-8. PubMed ID: 17952434
[TBL] [Abstract][Full Text] [Related]
4. Effects of no flow and reperfusion on technetium-99m-Q12 kinetics.
Okada RD; Nguyen KN; Lauinger M; Allton IL; Spreitzer K; Beju D; Johnson G
J Nucl Med; 1995 Nov; 36(11):2103-9. PubMed ID: 7472606
[TBL] [Abstract][Full Text] [Related]
5. Comparison of sestamibi, tetrofosmin, and Q12 retention in porcine myocardium.
Matsunari I; Haas F; Nguyen NT; Reidel G; Wolf I; Senekowitsch-Schmidtke R; Stöcklin G; Schwaiger M
J Nucl Med; 2001 May; 42(5):818-23. PubMed ID: 11337582
[TBL] [Abstract][Full Text] [Related]
6. 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 in vitro and in vivo.
Bernard BF; Krenning EP; Breeman WA; Ensing G; Benjamins H; Bakker WH; Visser TJ; de Jong M
Nucl Med Biol; 1998 Apr; 25(3):233-40. PubMed ID: 9620628
[TBL] [Abstract][Full Text] [Related]
7. Myocardial kinetics of (201)Thallium, (99m)Tc-tetrofosmin, and (99m)Tc-sestamibi in an acute ischemia-reperfusion model using isolated rat heart.
Fukushima K; Momose M; Kondo C; Kusakabe K; Kasanuki H
Ann Nucl Med; 2007 Jul; 21(5):267-73. PubMed ID: 17634844
[TBL] [Abstract][Full Text] [Related]
8. 201Tl, 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin: relative retention and clearance kinetics in retrogradely perfused guinea pig hearts.
Schaefer WM; Moka D; Brockmann HA; Schomaecker K; Schicha H
Nucl Med Biol; 2002 Feb; 29(2):243-54. PubMed ID: 11823130
[TBL] [Abstract][Full Text] [Related]
9. 99mTc-glucarate kinetics differentiate normal, stunned, hibernating, and nonviable myocardium in a perfused rat heart model.
Okada DR; Liu Z; Johnson G; Beju D; Khaw BA; Okada RD
Eur J Nucl Med Mol Imaging; 2010 Oct; 37(10):1909-17. PubMed ID: 20652807
[TBL] [Abstract][Full Text] [Related]
10. Technetium-99m-tetrofosmin, technetium-99m-MIBI and thallium-201 uptake in rat myocardial cells.
Arbab AS; Koizumi K; Toyama K; Arai T; Araki T
J Nucl Med; 1998 Feb; 39(2):266-71. PubMed ID: 9476934
[TBL] [Abstract][Full Text] [Related]
11. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease.
Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M
J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532
[TBL] [Abstract][Full Text] [Related]
12. 99mTc-N-DBODC5, a new myocardial perfusion imaging agent with rapid liver clearance: comparison with 99mTc-sestamibi and 99mTc-tetrofosmin in rats.
Hatada K; Riou LM; Ruiz M; Yamamichi Y; Duatti A; Lima RL; Goode AR; Watson DD; Beller GA; Glover DK
J Nucl Med; 2004 Dec; 45(12):2095-101. PubMed ID: 15585487
[TBL] [Abstract][Full Text] [Related]
13. Correlations between uptake of technetium-99m Q12 and thallium-201: myocardial perfusion and viability in a model of acute coronary reperfusion.
Takahashi N; Reinhardt CP; Marcel R; Leppo JA
J Nucl Med; 1998 Jan; 39(1):159-65. PubMed ID: 9443756
[TBL] [Abstract][Full Text] [Related]
14. Clearance of technetium 99m N-NOET in normal, ischemic-reperfused, and membrane-disrupted myocardium.
Johnson G; Allton IL; Nguyen KN; Lauinger JM; Beju D; Pasqualini R; Duatti A; Okada RD
J Nucl Cardiol; 1996; 3(1):42-54. PubMed ID: 8799227
[TBL] [Abstract][Full Text] [Related]
15. Kinetics of technetium-99m-teboroxime in reperfused nonviable myocardium.
Okada RD; Glover DK; Moffett JD; Beju D; Johnson G
J Nucl Med; 1997 Feb; 38(2):274-9. PubMed ID: 9025755
[TBL] [Abstract][Full Text] [Related]
16. Reliability of technetium-99m Q12 and thallium-201 myocardial activity measurements after triphenyl tetrazolium chloride myocardial staining by perfusion.
Lenihan DJ; McGoron AJ; Gabel M; Walsh RA; Gerson MC
Invest Radiol; 1999 Apr; 34(4):276-81. PubMed ID: 10196719
[TBL] [Abstract][Full Text] [Related]
17. Myocardial kinetics of technetium-99m teboroxime in the presence of postischemic injury, necrosis and low flow reperfusion.
Beanlands RS; DeKemp RA; Harmsen E; Veinot JP; Hartman NG; Ruddy TD
J Am Coll Cardiol; 1996 Aug; 28(2):487-94. PubMed ID: 8800130
[TBL] [Abstract][Full Text] [Related]
18. HL-91-technetium-99m: a new marker of viability in ischemic myocardium.
Okada RD; Johnson G; Nguyen KN; Carlson LR; Beju D
J Nucl Cardiol; 1999; 6(3):306-15. PubMed ID: 10385186
[TBL] [Abstract][Full Text] [Related]
19. Extraction and retention of technetium-99m Q12, technetium-99m sestamibi, and thallium-201 in isolated rat heart during coronary acidemia.
McGoron AJ; Gerson MC; Biniakiewicz DS; Roszell NJ; Washburn LC; Millard RW
Eur J Nucl Med; 1997 Dec; 24(12):1479-86. PubMed ID: 9391182
[TBL] [Abstract][Full Text] [Related]
20. Kinetic analysis of 99mTc-sestamibi evaluates the protective effects by ischaemic preconditioning on ischaemic myocardium in an isolated rabbit heart.
Liang J; Chen HL; Zhou Y; Xie M; Xu LM; Lin G
Nucl Med Commun; 2007 Nov; 28(11):864-9. PubMed ID: 17901770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]